Li S, Liu Z, Li T, Tang Z, Feng Y, Chen C, Gu C, Chen J. Tubulin-based dual-target compounds and protein degraders for cancer therapy-An updated review (2021-present). Eur J Med Chem. 2026 Jan 5;301:118191.
- DOI:
http://dx.doi.org/10.1016/j.ejmech.2025.118191
Mousavi A, Moradi M, Firoozpour L, Foroumadi A. Verubulin and its derivatives: Progress and promise in tubulin-targeted cancer therapy. Eur J Med Chem. 2025 Dec 15;300:118112.
- DOI:
http://dx.doi.org/10.1016/j.ejmech.2025.118112